NRBP1 antibodies are widely used to investigate the protein’s role in cancer biology and signaling pathways. Key applications include:
Triple-Negative Breast Cancer (TNBC): Detects elevated NRBP1 expression linked to poor prognosis and metastasis via Rac1/Cdc42 activation .
Colorectal Cancer (CRC): Identifies NRBP1 as a tumor suppressor that induces caspase-dependent apoptosis .
Bladder Cancer: Highlights NRBP1’s pro-tumorigenic role in proliferation and lymph node metastasis .
Pro-Tumorigenic: In TNBC, NRBP1 promotes metastasis via P-Rex1-mediated Rac1 activation . In bladder cancer, high NRBP1 expression correlates with advanced tumor stage .
Tumor-Suppressive: In CRC, NRBP1 induces apoptosis through JNK/caspase-9 signaling .
NRBP1 scaffolds P-Rex1 to enhance GTP-bound Rac1/Cdc42 levels, driving TNBC cell migration .
NRBP1 knockdown in bladder cancer reduces Ki-67 (proliferation marker) and increases cleaved caspase-3 (apoptosis marker) .
Sample Preparation: Use RIPA buffer for protein extraction.
Detection: Chemiluminescence with HRP-conjugated secondary antibodies .
Staining Protocol: Heat-induced antigen retrieval, DAB chromogen, hematoxylin counterstain .
Scoring System: Immunoreactivity score (0–12) based on staining intensity and distribution .
NRBP1 (Nuclear Receptor Binding Protein 1) plays a role in intracellular trafficking between the endoplasmic reticulum and Golgi apparatus. This function is mediated through interactions with Rho-type GTPases. Studies indicate that NRBP1's interaction with the dengue virus type 2 NS3 protein disrupts this trafficking, leading to alterations in intracellular membrane structure associated with viral replication.